Developer docs
API playgroundTry for free, no card

Search company profiles

International Foundation for Gastrointestinal Disorders

Full company profile

uuid003n4o1

Namestring
International Foundation for Gastrointestinal Disorders
Legal namestring
International Foundation for Gastrointestinal Disorders, Inc.
Websiteurl
iffgd.org
Company typeenum
Private
Founded yearint
1991
Descriptiontext

The International Foundation for Gastrointestinal Disorders (IFFGD) is a 501(c)(3) nonprofit organization founded in 1991 and headquartered in Mt. Pleasant, South Carolina (incorporated as a Wisconsin nonstock corporation). The organization informs, assists, and supports people affected by gastrointestinal (GI) disorders — including IBS, GERD, gastroparesis, chronic constipation, chronic diarrhea, fecal incontinence, and pediatric GI conditions — through free educational content, a publications library, monthly newsletters, virtual events, and the Norton Education Series. It also funds investigator-initiated research via the Nancy and Bill Norton Research Program and conducts federal advocacy (Capitol Hill Advocacy Day, FGIMD Act support) to advance awareness and research prioritization for functional GI and motility disorders.

IFFGD's core "product" is a digital content and community platform rather than a technology product. The platform comprises iffgd.org, 13+ condition-specific microsites (About IBS, About GERD, About Constipation, About Gastroparesis, About GI Motility, About Incontinence, About Kids GI, plus patient-companion and Spanish-language sites), a publications library, video corner, searchable dietitian directory, and Patient Panel / Survey Corner for research engagement. Content is bilingual (English/Spanish) and distributed globally via the website, monthly eNewsletter, YouTube, Facebook, Instagram, and X. All educational resources are provided free of charge.

The business model is nonprofit donation- and grant-funded. Revenue derives from individual donations, Industry Council memberships (Patron-level: AbbVie, Ironwood Pharmaceuticals, Pfizer, Takeda; Associate-level: Ardelyx, Braintree Laboratories, Enterra Medical, MBiota, Nestlé, Phathom Pharmaceuticals, Salix Pharmaceuticals, Vanda Pharmaceuticals), and likely event/program grants. The organization operates with 1-10 employees and holds registered trademarks for "International Foundation for Gastrointestinal Disorders" and "IFFGD." It has been recognized with the Candid Platinum Seal of Transparency, GuideStar Platinum Seal, and NORD Platinum Member status, underscoring long-standing institutional credibility rather than commercial scale.

Short descriptiontext

IFFGD is a 501(c)(3) nonprofit founded in 1991 that provides free educational resources, research funding, and advocacy for patients affected by gastrointestinal disorders, serving a global community of patients, caregivers, healthcare professionals, and researchers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMount Pleasant, United States
HQ citystring
Mount Pleasant
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
gastrointestinal disorder education, digestive health advocacy, patient education resources, GI research funding, nonprofit health support
Industry1 code
1Community Health, Health Promotion & Behavior Change (SBCC)
CodeBPADAIALPrimaryYes
NAICS code2 codes
  • Voluntary Health Organizations813212
  • Educational Support Services611710
SIC code1 code
  • Services-Misc Health & Allied Services, Nec8090
Product category
Patient Education and Health Advocacy
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Donations and Contributions
TypeAffiliate Referral
Description

IFFGD is funded primarily through donations from individuals and organizations who support their mission to inform, assist, and support people affected by gastrointestinal disorders. The website includes a donate button and mentions that donations allow funding of life-changing research and educational programs.

iffgd.org
2Industry Council Memberships
TypeProfessional Services
Description

IFFGD acknowledges industry partners at Patron and Associate levels who support the organization. These pharmaceutical and medical device companies provide funding through the Industry Council program.

iffgd.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
Pricing details1 tier
1Free membership and newsletter subscription
ModelFreemiumBilling cadenceMonthly
Notes

All IFFGD services are provided free of charge including educational publications, newsletters, clinical trial information, dietitian listings, and patient resources. The organization operates as a 501(c)(3) nonprofit supported by donations.

iffgd.org
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 17 records shown
1About IBS
Description

Dedicated website for Irritable Bowel Syndrome information and resources

iffgd.org
+16 more records
Core offering1 text field

The International Foundation for Gastrointestinal Disorders (IFFGD) is a 501(c)(3) nonprofit that informs, assists, and supports people affected by gastrointestinal disorders. It provides free educational content about GI conditions, funds research through the Nancy and Bill Norton Research Program, runs advocacy campaigns including Capitol Hill Advocacy Day, and delivers community programming such as the Norton Education Series and the Digestive Health Monthly eNewsletter.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 30+ years serving the GI community with educational resources and support
+2 more records
Product overview1 text field

The International Foundation for Gastrointestinal Disorders (IFFGD) operates a comprehensive educational and research ecosystem rather than a traditional tech product. The core offering is iffgd.org, a nonprofit informational website providing reliable knowledge, support, and assistance about gastrointestinal disorders. This is complemented by a network of condition-specific companion websites (About Constipation, About IBS, About GERD, About Gastroparesis, About GI Motility, About Incontinence, About Kids GI) that provide targeted information for specific GI conditions. The organization's digital portfolio includes publications and resources (Publications Library, Video Corner, Dietitians Listing, Patient Resources), engagement platforms (Digestive Health Monthly eNewsletter, Advocacy Connection Newsletter, IFFGD Patient Panel), educational programming (Norton Education Series), and research initiatives (IFFGD Nancy and Bill Norton Research Program including grants, awards, and travel awards). All offerings are nonprofit educational resources designed to inform, assist, and support people affected by gastrointestinal disorders.

Product and service9 records
1IFFGD Main Website (iffgd.org)
CategoryEducational Resource
Description

The flagship iffgd.org website provides reliable information on GI disorders, symptoms, treatments, healthcare provider listings, publications, and educational content for patients, caregivers, and healthcare professionals.

2Condition-Specific Companion Websites
CategoryEducational Resource
Description

A network of dedicated websites covering specific GI conditions including About IBS, About Constipation, About GERD, About Gastroparesis, About GI Motility, About Incontinence, About Kids GI, You and IBS, You and Constipation, You and Colonoscopy, and Los Niños y GI.

3Digestive Health Monthly eNewsletter
CategoryNewsletter
Description

A free monthly eNewsletter providing the latest news on treatments and research breakthroughs, educational articles, tips for daily life with GI disorders, patient advocate spotlights, and clinical trial opportunities.

4Advocacy Connection Newsletter
CategoryNewsletter
Description

Newsletter with updates on relevant legislation, IFFGD visits to Washington D.C., government agency updates, and advocacy-related information.

5Norton Education Series
CategoryEducational Programming
Description

Educational programs covering GI symptoms overview, gut microbiome, irritable bowel syndrome, and other digestive health topics, featuring expert speakers from the digestive health community.

6Nancy and Bill Norton Research Program
CategoryResearch Grants
Description

Research funding initiative that awards grants and travel awards to investigators focused on functional gastrointestinal and motility disorders, including research awards, grants, and preceptorship awards.

7Publications Library
CategoryEducational Resource
Description

A comprehensive library of educational publications about GI disorders, symptoms, and treatments available for download by patients and healthcare professionals.

8Dietitians Listing
CategoryProvider Directory
Description

A searchable database of registered dietitians with experience in gastrointestinal and motility disorders, allowing users to filter by state, city, specialty, and insurance acceptance.

9IFFGD Patient Panel
CategoryResearch Participation
Description

A patient engagement initiative that allows individuals to participate in surveys and research studies to help advance understanding of GI disorders.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Larger, established professional gastroenterology society with a much broader mandate than IFFGD, including research funding, publications, and patient education. Overlaps with IFFGD on patient-facing GI content and research grant programs but serves the entire GI specialty rather than focusing on functional/motility disorders.

TypeBroad incumbent
Description

National professional society for gastroenterologists with patient education content, clinical guidelines, and research programs. Comparable to IFFGD in serving GI patients and professionals but operates at significantly larger scale and as a clinician membership organization rather than a patient-led nonprofit.

TypeDirect peer
Description

Major U.S. nonprofit focused on inflammatory bowel diseases (Crohn's disease and ulcerative colitis). Directly comparable as a digestive-disease patient advocacy, education, and research-funding organization operating with similar mission, funding model (donations + industry council), and audience overlap with IFFGD.

TypeEmerging player
Description

Digital medical education platform delivering continuing medical education, podcasts, and expert content to healthcare professionals. Comparable as a digital health education channel reaching clinicians and engaged patients, though broader than IFFGD across all therapeutic areas.

5UNC Center for Functional GI & Motility Disorders
TypeEmerging player
Description

Academic center of excellence at UNC focused on functional GI and motility disorders — the same niche as IFFGD. Overlaps heavily on patient education content and research, but operates as an academic medical center rather than a patient advocacy nonprofit.

TypeRegional player
Description

U.S.-based professional nursing society for GI nurses and associates, providing education, training, and practice resources. Comparable to IFFGD's professional education and community mission but focused on the nursing workforce rather than patients directly.

TypeBroad incumbent
Description

Umbrella advocacy organization for rare diseases, of which IFFGD is a Platinum Member. Comparable as a nonprofit raising funds and advocating for under-served patient communities, though NORD's scope is far broader (300+ disease areas) versus IFFGD's narrower GI focus.

TypeDirect peer
Description

Patient advocacy organization focused specifically on gastrointestinal motility disorders — the same core niche IFFGD addresses. Directly comparable mission, audience, and resource scope, and a clear head-to-head peer for patient and researcher mindshare in motility-related GI conditions.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

International Foundation for Gastrointestinal Disorders

Patient Education and Health Advocacyiffgd.org

IFFGD is a 501(c)(3) nonprofit founded in 1991 that provides free educational resources, research funding, and advocacy for patients affected by gastrointestinal disorders, serving a global community of patients, caregivers, healthcare professionals, and researchers.

What International Foundation for Gastrointestinal Disorders does

The International Foundation for Gastrointestinal Disorders (IFFGD) is a 501(c)(3) nonprofit organization founded in 1991 and headquartered in Mt. Pleasant, South Carolina (incorporated as a Wisconsin nonstock corporation). The organization informs, assists, and supports people affected by gastrointestinal (GI) disorders — including IBS, GERD, gastroparesis, chronic constipation, chronic diarrhea, fecal incontinence, and pediatric GI conditions — through free educational content, a publications library, monthly newsletters, virtual events, and the Norton Education Series. It also funds investigator-initiated research via the Nancy and Bill Norton Research Program and conducts federal advocacy (Capitol Hill Advocacy Day, FGIMD Act support) to advance awareness and research prioritization for functional GI and motility disorders.

IFFGD's core "product" is a digital content and community platform rather than a technology product. The platform comprises iffgd.org, 13+ condition-specific microsites (About IBS, About GERD, About Constipation, About Gastroparesis, About GI Motility, About Incontinence, About Kids GI, plus patient-companion and Spanish-language sites), a publications library, video corner, searchable dietitian directory, and Patient Panel / Survey Corner for research engagement. Content is bilingual (English/Spanish) and distributed globally via the website, monthly eNewsletter, YouTube, Facebook, Instagram, and X. All educational resources are provided free of charge.

The business model is nonprofit donation- and grant-funded. Revenue derives from individual donations, Industry Council memberships (Patron-level: AbbVie, Ironwood Pharmaceuticals, Pfizer, Takeda; Associate-level: Ardelyx, Braintree Laboratories, Enterra Medical, MBiota, Nestlé, Phathom Pharmaceuticals, Salix Pharmaceuticals, Vanda Pharmaceuticals), and likely event/program grants. The organization operates with 1-10 employees and holds registered trademarks for "International Foundation for Gastrointestinal Disorders" and "IFFGD." It has been recognized with the Candid Platinum Seal of Transparency, GuideStar Platinum Seal, and NORD Platinum Member status, underscoring long-standing institutional credibility rather than commercial scale.

International Foundation for Gastrointestinal Disorders firmographics

Firmographics
Name
International Foundation for Gastrointestinal Disorders
Legal name
International Foundation for Gastrointestinal Disorders, Inc.
Website
https://iffgd.org
Company type
Private
Founded year
1991
Operating status
Operating
Headcount range
1–10 employees
Short description
IFFGD is a 501(c)(3) nonprofit founded in 1991 that provides free educational resources, research funding, and advocacy for patients affected by gastrointestinal disorders, serving a global community of patients, caregivers, healthcare professionals, and researchers.
Ownership category
akta.pro rank

International Foundation for Gastrointestinal Disorders industry classification

Industry
Product category
Patient Education and Health Advocacy
NAICS
Voluntary Health Organizations (813212), Educational Support Services (611710)
SIC
Services-Misc Health & Allied Services, Nec (8090)
akta.pro primary industry
Community Health, Health Promotion & Behavior Change (SBCC) (BPADAIAL)

Keywords

  • Gastrointestinal disorder education
  • Digestive health advocacy
  • Patient education resources
  • GI research funding
  • Nonprofit health support

Where International Foundation for Gastrointestinal Disorders is headquartered

Location

Headquarters

HQ city
Mount Pleasant
HQ country
United States
HQ region
North America

Offices1 record

Markets served

International Foundation for Gastrointestinal Disorders business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Donations and Contributions: IFFGD is funded primarily through donations from individuals and organizations who support their mission to inform, assist, and support people affected by gastrointestinal disorders. The website includes a donate button and mentions that donations allow funding of life-changing research and educational programs.
  2. Industry Council Memberships: IFFGD acknowledges industry partners at Patron and Associate levels who support the organization. These pharmaceutical and medical device companies provide funding through the Industry Council program.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree membership and newsletter subscription

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

International Foundation for Gastrointestinal Disorders product offering

Product offering

Core offering

The International Foundation for Gastrointestinal Disorders (IFFGD) is a 501(c)(3) nonprofit that informs, assists, and supports people affected by gastrointestinal disorders. It provides free educational content about GI conditions, funds research through the Nancy and Bill Norton Research Program, runs advocacy campaigns including Capitol Hill Advocacy Day, and delivers community programming such as the Norton Education Series and the Digestive Health Monthly eNewsletter.

Product overview

The International Foundation for Gastrointestinal Disorders (IFFGD) operates a comprehensive educational and research ecosystem rather than a traditional tech product. The core offering is iffgd.org, a nonprofit informational website providing reliable knowledge, support, and assistance about gastrointestinal disorders. This is complemented by a network of condition-specific companion websites (About Constipation, About IBS, About GERD, About Gastroparesis, About GI Motility, About Incontinence, About Kids GI) that provide targeted information for specific GI conditions. The organization's digital portfolio includes publications and resources (Publications Library, Video Corner, Dietitians Listing, Patient Resources), engagement platforms (Digestive Health Monthly eNewsletter, Advocacy Connection Newsletter, IFFGD Patient Panel), educational programming (Norton Education Series), and research initiatives (IFFGD Nancy and Bill Norton Research Program including grants, awards, and travel awards). All offerings are nonprofit educational resources designed to inform, assist, and support people affected by gastrointestinal disorders.

Differentiator

Problem solved

Functional benefit

Brands

  • About IBS: Dedicated website for Irritable Bowel Syndrome information and resources
  • About Constipation
  • About GERD
  • About Gastroparesis
  • About GI Motility
  • About Incontinence
  • About Kids GI
  • You and IBS
  • You and Constipation
  • You and Colonoscopy
  • Los Niños y GI
  • Digestive Health Matters
  • Digestive Health Monthly
  • Advocacy Connection Newsletter
  • Nancy and Bill Norton Research Program
  • Norton Education Series
  • Young Advocates in GI

Products and services

  • IFFGD Main Website (iffgd.org) The flagship iffgd.org website provides reliable information on GI disorders, symptoms, treatments, healthcare provider listings, publications, and educational content for patients, caregivers, and healthcare professionals.
  • Condition-Specific Companion Websites A network of dedicated websites covering specific GI conditions including About IBS, About Constipation, About GERD, About Gastroparesis, About GI Motility, About Incontinence, About Kids GI, You and IBS, You and Constipation, You and Colonoscopy, and Los Niños y GI.
  • Digestive Health Monthly eNewsletter A free monthly eNewsletter providing the latest news on treatments and research breakthroughs, educational articles, tips for daily life with GI disorders, patient advocate spotlights, and clinical trial opportunities.
  • Advocacy Connection Newsletter Newsletter with updates on relevant legislation, IFFGD visits to Washington D.C., government agency updates, and advocacy-related information.
  • Norton Education Series Educational programs covering GI symptoms overview, gut microbiome, irritable bowel syndrome, and other digestive health topics, featuring expert speakers from the digestive health community.
  • Nancy and Bill Norton Research Program Research funding initiative that awards grants and travel awards to investigators focused on functional gastrointestinal and motility disorders, including research awards, grants, and preceptorship awards.
  • Publications Library A comprehensive library of educational publications about GI disorders, symptoms, and treatments available for download by patients and healthcare professionals.
  • Dietitians Listing A searchable database of registered dietitians with experience in gastrointestinal and motility disorders, allowing users to filter by state, city, specialty, and insurance acceptance.
  • IFFGD Patient Panel A patient engagement initiative that allows individuals to participate in surveys and research studies to help advance understanding of GI disorders.

Quantifiable outcome

  • 30+ years serving the GI community with educational resources and support
  • +2 more outcomes

Companies that use International Foundation for Gastrointestinal Disorders

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

International Foundation for Gastrointestinal Disorders technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

International Foundation for Gastrointestinal Disorders partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

International Foundation for Gastrointestinal Disorders competitors and assessment

Company assessment

Broad incumbents

  • American Gastroenterological Association (AGA): Larger, established professional gastroenterology society with a much broader mandate than IFFGD, including research funding, publications, and patient education. Overlaps with IFFGD on patient-facing GI content and research grant programs but serves the entire GI specialty rather than focusing on functional/motility disorders.
  • American College of Gastroenterology (ACG): National professional society for gastroenterologists with patient education content, clinical guidelines, and research programs. Comparable to IFFGD in serving GI patients and professionals but operates at significantly larger scale and as a clinician membership organization rather than a patient-led nonprofit.
  • National Organization for Rare Disorders (NORD): Umbrella advocacy organization for rare diseases, of which IFFGD is a Platinum Member. Comparable as a nonprofit raising funds and advocating for under-served patient communities, though NORD's scope is far broader (300+ disease areas) versus IFFGD's narrower GI focus.

Direct peers

  • Crohn's & Colitis Foundation: Major U.S. nonprofit focused on inflammatory bowel diseases (Crohn's disease and ulcerative colitis). Directly comparable as a digestive-disease patient advocacy, education, and research-funding organization operating with similar mission, funding model (donations + industry council), and audience overlap with IFFGD.
  • Association of Gastrointestinal Motility Disorders (AGMD): Patient advocacy organization focused specifically on gastrointestinal motility disorders — the same core niche IFFGD addresses. Directly comparable mission, audience, and resource scope, and a clear head-to-head peer for patient and researcher mindshare in motility-related GI conditions.

Emerging players

  • ReachMD: Digital medical education platform delivering continuing medical education, podcasts, and expert content to healthcare professionals. Comparable as a digital health education channel reaching clinicians and engaged patients, though broader than IFFGD across all therapeutic areas.
  • UNC Center for Functional GI & Motility Disorders: Academic center of excellence at UNC focused on functional GI and motility disorders — the same niche as IFFGD. Overlaps heavily on patient education content and research, but operates as an academic medical center rather than a patient advocacy nonprofit.

Regional players

  • Society of Gastroenterology Nurses and Associates (SGNA): U.S.-based professional nursing society for GI nurses and associates, providing education, training, and practice resources. Comparable to IFFGD's professional education and community mission but focused on the nursing workforce rather than patients directly.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

International Foundation for Gastrointestinal Disorders social profiles

Digital presence

International Foundation for Gastrointestinal Disorders financial estimates

Financial estimate

Revenue estimate

Valuation estimate

International Foundation for Gastrointestinal Disorders leadership team

Management profile

Number of profiles

Profiles1 record

International Foundation for Gastrointestinal Disorders funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

International Foundation for Gastrointestinal Disorders M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Foundation for Gastrointestinal Disorders

What does International Foundation for Gastrointestinal Disorders do?

The International Foundation for Gastrointestinal Disorders (IFFGD) is a 501(c)(3) nonprofit that informs, assists, and supports people affected by gastrointestinal disorders. It provides free educational content about GI conditions, funds research through the Nancy and Bill Norton Research Program, runs advocacy campaigns including Capitol Hill Advocacy Day, and delivers community programming such as the Norton Education Series and the Digestive Health Monthly eNewsletter.

Is International Foundation for Gastrointestinal Disorders a public or private company?

International Foundation for Gastrointestinal Disorders is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was International Foundation for Gastrointestinal Disorders founded?

International Foundation for Gastrointestinal Disorders was founded in 1991. It employs 1 to 10 people.

Where is International Foundation for Gastrointestinal Disorders based?

International Foundation for Gastrointestinal Disorders is headquartered in Mount Pleasant, United States, in the North America region.

How does International Foundation for Gastrointestinal Disorders make money?

Two revenue lines are on record. Donations and Contributions are the primary driver. The others are industry Council Memberships.

Who are International Foundation for Gastrointestinal Disorders's main competitors?

Broad incumbents on record are American Gastroenterological Association (AGA), American College of Gastroenterology (ACG) and National Organization for Rare Disorders (NORD). Direct peers are Crohn's & Colitis Foundation and Association of Gastrointestinal Motility Disorders (AGMD). Emerging players are ReachMD and UNC Center for Functional GI & Motility Disorders. Society of Gastroenterology Nurses and Associates (SGNA) is listed as a regional player.

Does International Foundation for Gastrointestinal Disorders have an API?

No public API is recorded for International Foundation for Gastrointestinal Disorders.

What industry is International Foundation for Gastrointestinal Disorders in?

International Foundation for Gastrointestinal Disorders's product category is Patient Education and Health Advocacy. Its primary akta.pro industry code is BPADAIAL, Community Health, Health Promotion & Behavior Change (SBCC). Its NAICS code is 813212 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireGastroparesis Awareness Month 2026: "More Than Invisible" Campaign Shines a Light on a Hidden Digestive DiseaseThe International Foundation for Gastrointestinal Disorders (IFFGD) has launched its "More Than Invisible" national awareness campaign during Gastroparesis Awareness Month to educate the public and empower patients living with gastroparesis, a chronic digestive disorder estimated to affect millions of people. The campaign will share educational resources, patient stories, expert interviews, and social media content to shorten diagnosis time and improve access to care for those affected by the condition. IFFGD President Ceciel T. Rooker stated that the initiative aims to give voice to patients whose daily struggles often go unnoticed, encouraging healthcare providers to consider gastroparesis when evaluating individuals with persistent upper gastrointestinal symptoms.PR Newswire2025 Constipation Awareness Month: Keep Things MovingThe International Foundation for Gastrointestinal Disorders (IFFGD) is leading a campaign for Constipation Awareness Month in December 2025 to promote education and reduce stigma surrounding digestive health. The organization highlights that constipation affects approximately one in six to seven people globally and encourages individuals to seek professional care for symptoms. IFFGD is providing resources such as a media toolkit and social campaigns to foster open dialogue about gastrointestinal disorders.PR Newswire2025 Let's Talk GERD: GERD Awareness Week Shines a Light on a Common Digestive DisorderThe International Foundation for Gastrointestinal Disorders (IFFGD) has launched its annual GERD Awareness Week campaign running November 23-29, 2025, centered on the theme #LetsTalkGERD to encourage public conversations about Gastroesophageal Reflux Disease. The organization aims to address the widespread misunderstanding of GERD symptoms, noting that the condition affects an estimated 1 in 5 adults in the United States and is the most prevalent gastrointestinal disorder in the country. IFFGD is using social media to amplify patient voices and provide resources including a GERD Symptom Tracker to help individuals seek proper diagnosis and treatment from healthcare providers.GlobeNewswireEvoke Pharma Recognizes Gastroparesis Awareness Month through its Support of The International Foundation for Gastrointestinal Disorders (IFFGD)Evoke Pharma announced its ongoing collaboration with the International Foundation for Gastrointestinal Disorders for Gastroparesis Awareness Month in August. The company and EVERSANA participated in the IFFGD's 2022 Virtual Digestive Health Wellness and Walk Event, finishing first with 3.1 million steps. Evoke will also attend the ANMS 2022 meeting in Philadelphia to discuss gastroparesis management.PR NewswireIBS Awareness Month: Breaking the StigmasThe International Foundation for Gastrointestinal Disorders (IFFGD) is leading IBS Awareness Month in April 2022 with the theme "Breaking the Stigmas" to destigmatize irritable bowel syndrome, which affects up to 45 million people in the United States. The campaign utilizes social media hashtags and includes a free in-person education event in Chicago, Illinois, hosted by IFFGD. IFFGD President Ceciel T. Rooker highlighted efforts to improve access to education materials and break common stigmas associated with IBS.GlobeNewswireEvoke Pharma and EVERSANA Announce Support of The International Foundation for Gastrointestinal Disorders’ (IFFGD) August Gastroparesis Awareness MonthEvoke Pharma and EVERSANA announced support for IFFGD's August Gastroparesis Awareness Month and sponsorship of the Digestive Health Virtual Walk. The walk runs August 21 to September 4, with proceeds funding a research grant for gastrointestinal disorders. Evoke will participate under Team DGP-n-Me.IffgdFundingThe IFFGD page states it receives funding from thousands of individual donors across the United States and abroad, plus corporate support from companies involved in gastrointestinal disorders or incontinence products, foundations and government agencies including the National Institutes of Health. The organization retains control over fund application and project planning, does not endorse specific products, and publishes financial information including Form 990 filings on Candid.org.PR NewswireIFFGD Raises Awareness for Gastroparesis Awareness Month to Encourage "Education"The International Foundation for Gastrointestinal Disorders (IFFGD) announced the fourth annual Gastroparesis Awareness Month in August 2019, with the theme "Education," to increase public understanding of the condition. Approximately five million people in the United States are affected by gastroparesis, a chronic digestive condition that typically takes an average of five years to diagnose. IFFGD is launching a social media campaign using the hashtag #GPeducation to provide educational resources and support for patients, families, and caregivers.PR NewswireSocial Taboos, Lack of Awareness May Prevent Diagnosis and Treatment of IBSThe International Foundation for Functional Gastrointestinal Disorders (IFFGD) is marking IBS Awareness Month in April to raise public understanding of irritable bowel syndrome, a chronic condition estimated to affect 30 to 45 million people in the United States. The organization highlights that IBS is the second leading cause of work absenteeism, causing those affected to restrict their activities an average of 73 days per year. IFFGD warns that social taboos surrounding bowel symptoms prevent many individuals from openly discussing their condition or seeking medical care, creating barriers to proper diagnosis and treatment.PR NewswireResearch Survey Reveals Unmet Needs of People With GastroparesisA survey published by the International Foundation for Functional Gastrointestinal Disorders (IFFGD) and researchers from Temple University School of Medicine found that people with gastroparesis struggle with symptoms for an average of 5 years before obtaining an accurate diagnosis. The survey of 1,423 respondents, published in Digestive Diseases and Sciences, revealed that general health and social function are especially decreased in affected individuals, with nausea, abdominal pain, and vomiting identified as the most troubling symptoms. The findings, announced during Gastroparesis Awareness Month, highlight the need for greater awareness and better treatments targeting both symptoms and quality of life issues.